(Q38616175)

4 September 2017

title

CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation (English)

1 reference

4 September 2017

A-S Tigan

1

1 reference

4 September 2017

F Bellutti

2

1 reference

4 September 2017

K Kollmann

3

1 reference

4 September 2017

G Tebb

4

1 reference

4 September 2017

V Sexl

5

1 reference

4 September 2017

language of work or name

English

0 references

publication date

26 October 2015

1 reference

4 September 2017

1 reference

4 September 2017

volume

35

1 reference

4 September 2017

issue

24

1 reference

4 September 2017

page(s)

3083-3091

1 reference

Cyclin-dependent kinases: a family portrait.

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cdks, cyclins and CKIs: roles beyond cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

To cycle or not to cycle: a critical decision in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cell cycle, CDKs and cancer: a changing paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Signaling through cyclin D-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Targeting cell cycle regulators in hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Identification of G1 kinase activity for cdk6, a novel cyclin D partner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Living with or without cyclins and cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

D-type cyclin-dependent kinase activity in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

CDK6 and p16INK4A in lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin-dependent kinases: engines, clocks, and microprocessors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Rb interacts with histone deacetylase to repress transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Retinoblastoma protein recruits histone deacetylase to repress transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Rb targets histone H3 methylation and HP1 to promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Regulation of transcription and chromatin structure by pRB: here, there and everywhere

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Conserved RB functions in development and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Multiple mechanisms for E2F binding inhibition by phosphorylation of the retinoblastoma protein C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cell cycle kinases as therapeutic targets for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

The regulation of E2F by pRB-family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

FOXM1, a typical proliferation-associated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin D1-cdk4 induce runx2 ubiquitination and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

CDK6 binds and promotes the degradation of the EYA2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Coordinated regulation of differentiation and proliferation of embryonic cardiomyocytes by a jumonji (Jarid2)-cyclin D1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin D3-dependent control of the dNTP pool and HIV-1 replication in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

CDK-mediated regulation of cell functions via c-Jun phosphorylation and AP-1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin-dependent kinases regulate the antiproliferative function of Smads

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

New functional activities for the p21 family of CDK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin D3-associated kinase activity is regulated by p27kip1 in BALB/c 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Genetic characterization of the role of the Cip/Kip family of proteins as cyclin-dependent kinase inhibitors and assembly factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Inhibition of cyclin-dependent kinases by p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

The p16INK4a/CDKN2A tumor suppressor and its relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Mammalian cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Requirement for CDK4 kinase function in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

CDK6 associates with the centrosome during mitosis and is mutated in a large Pakistani family with primary microcephaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Whole genomes redefine the mutational landscape of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Requirement for CDK6 in MLL-rearranged acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

The landscape of somatic copy-number alteration across human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Signatures of mutation and selection in the cancer genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

A cell cycle regulator potentially involved in genesis of many tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

p16INK4A is a robust in vivo biomarker of cellular aging in human skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Tailoring to RB: tumour suppressor status and therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

The requirement for cyclin D function in tumor maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Modification of the DNA damage response by therapeutic CDK4/6 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

CDK6, a new target in MLL-driven leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

CDK6 blocks differentiation: coupling cell proliferation to the block to differentiation in leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

PU.1 directly regulates cdk6 gene expression, linking the cell proliferation and differentiation programs in erythroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Osteoclast differentiation by RANKL requires NF-kappaB-mediated downregulation of cyclin-dependent kinase 6 (Cdk6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPalpha interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

CDK6 kinase activity is required for thymocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Negative regulation of TSC1-TSC2 by mammalian D-type cyclins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin-dependent kinase 6 is a chromatin-bound cofactor for NF-κB-dependent gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin-dependent kinase 6 phosphorylates NF-κB P65 at serine 536 and contributes to the regulation of inflammatory gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

The dark and the bright side of Stat3: proto-oncogene and tumor-suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

CDK6 levels regulate quiescence exit in human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

CDK6 as a key regulator of hematopoietic and leukemic stem cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

CDK6 is a regulator of stem cells "Egr" to wake up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

21 January 2018

New roles of cyclin D1.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Minireview: Cyclin D1: normal and abnormal functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Transcriptional regulation by a DNA-associated form of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Dmp1 and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Alternative cyclin D1 splice forms differentially regulate the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Proteomic identification of a direct role for cyclin d1 in DNA damage repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin d1 induces chromosomal instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Kinase independent oncogenic cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Physical interaction of the retinoblastoma protein with human D cyclins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Function of a human cyclin gene as an oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin D1 is a NF-κB corepressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Unexpected outcomes of CDK4/6 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cell-cycle control of developmentally regulated transcription factors accounts for heterogeneity in human pluripotent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Therapeutic targets in the ARF tumor suppressor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

The ARF tumour suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

The Stat3 paradox: a killer and an oncogene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Inflammation meets cancer, with NF-κB as the matchmaker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

NF-κB and the link between inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Moonlighting proteins: an intriguing mode of multitasking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

A family of human cdc2-related protein kinases

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FONC.2015.407

31 March 2020

12 December 2020

Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Expression of cyclin-dependent kinase 6 (cdk6) and frequent loss of CD44 in nasal-nasopharyngeal NK/T-cell lymphomas: comparison with CD56-negative peripheral T-cell lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

In B-cell chronic lymphocytic leukemias, 7q21 translocations lead to overexpression of the CDK6 gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

The diverse and complex roles of NF-κB subunits in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.407

Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia.

31 March 2020

1 reference

12 December 2020

Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4.

1 reference

12 December 2020

CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

1 reference

12 December 2020

D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability

1 reference

12 December 2020

Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.

1 reference

12 December 2020

CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.

1 reference

12 December 2020

Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes

1 reference

12 December 2020

Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemia

1 reference

12 December 2020

Cell cycle inhibitors make progress.

1 reference

12 December 2020

Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation.

1 reference

12 December 2020

Identifiers

DOI

10.1038/ONC.2015.407

1 reference

Dimensions Publication ID

4 September 2017

1041359135

0 references

Fatcat ID

release_sx35fsev6bgqtfvycluqxoplpq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sx35fsev6bgqtfvycluqxoplpq

24 November 2022

mapped directly with Wikidata item

1 reference